Hollsteen
← Broadcom

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 FY2016: $5.1B · 10-Q 0001649338-16-000019 filed Mar 10, 2016Equity incl. NCI · Q2 FY2016: $22.8B · 10-Q 0001649338-16-000088 filed Jun 9, 2016Equity incl. NCI · Q3 FY2016: $22.5B · 10-Q 0001649338-16-000104 filed Sep 8, 2016Equity incl. NCI · Q4 FY2016: $21.9B · 10-K 0001730168-18-000084 filed Dec 21, 2018Equity incl. NCI · Q1 FY2017: $22.0B · 10-Q 0001649338-17-000027 filed Mar 9, 2017Equity incl. NCI · Q2 FY2017: $22.3B · 10-Q 0001649338-17-000093 filed Jun 8, 2017Equity incl. NCI · Q3 FY2017: $22.7B · 10-Q 0001649338-17-000107 filed Sep 7, 2017Equity incl. NCI · Q4 FY2017: $23.2B · 10-K 0001730168-18-000084 filed Dec 21, 2018Equity incl. NCI · Q1 FY2018: $29.1B · 10-Q 0001730168-18-000019 filed Jun 14, 2018Equity incl. NCI · Q2 FY2018: $32.1B · 10-Q 0001730168-18-000019 filed Jun 14, 2018Equity incl. NCI · Q3 FY2018: $27.5B · 10-Q 0001730168-18-000039 filed Sep 13, 2018Equity incl. NCI · Q4 FY2018: $26.7B · 10-K 0001730168-18-000084 filed Dec 21, 2018Equity incl. NCI · Q1 FY2019: $23.2B · 10-Q 0001730168-19-000036 filed Mar 15, 2019Equity incl. NCI · Q2 FY2019: $22.2B · 10-Q 0001730168-19-000101 filed Jun 14, 2019Equity incl. NCI · Q3 FY2019: $21.5B · 10-Q 0001730168-19-000118 filed Sep 13, 2019Equity incl. NCI · Q4 FY2019: $24.9B · 10-K 0001730168-19-000144 filed Dec 20, 2019Equity incl. NCI · Q1 FY2020: $24.4B · 10-Q 0001730168-20-000045 filed Mar 13, 2020Equity incl. NCI · Q2 FY2020: $23.9B · 10-Q 0001730168-20-000109 filed Jun 12, 2020Equity incl. NCI · Q3 FY2020: $23.6B · 10-Q 0001730168-20-000164 filed Sep 11, 2020Equity incl. NCI · Q4 FY2020: $23.9B · 10-K 0001730168-20-000226 filed Dec 18, 2020Equity incl. NCI · Q1 FY2021: $24.0B · 10-Q 0001730168-21-000045 filed Mar 12, 2021Equity incl. NCI · Q2 FY2021: $23.9B · 10-Q 0001730168-21-000116 filed Jun 11, 2021Equity incl. NCI · Q3 FY2021: $24.3B · 10-Q 0001730168-21-000123 filed Sep 9, 2021Equity incl. NCI · Q4 FY2021: $25.0B · 10-K 0001730168-21-000153 filed Dec 17, 2021Equity incl. NCI · Q1 FY2022: $23.0B · 10-Q 0001730168-22-000029 filed Mar 10, 2022Equity incl. NCI · Q2 FY2022: $21.0B · 10-Q 0001730168-22-000081 filed Jun 9, 2022Equity incl. NCI · Q3 FY2022: $20.9B · 10-Q 0001730168-22-000094 filed Sep 8, 2022Equity incl. NCI · Q4 FY2022: $22.7B · 10-K 0001730168-22-000118 filed Dec 16, 2022Equity incl. NCI · Q1 FY2023: $23.3B · 10-Q 0001730168-23-000008 filed Mar 8, 2023Equity incl. NCI · Q2 FY2023: $22.0B · 10-Q 0001730168-23-000064 filed Jun 7, 2023Equity incl. NCI · Q3 FY2023: $22.1B · 10-Q 0001730168-23-000077 filed Sep 6, 2023Equity incl. NCI · Q4 FY2023: $24.0B · 10-K 0001730168-23-000096 filed Dec 14, 2023Equity incl. NCI · Q1 FY2024: $70.3B · 10-Q 0001730168-24-000023 filed Mar 14, 2024Equity incl. NCI · Q2 FY2024: $70.0B · 10-Q 0001730168-24-000080 filed Jun 13, 2024Equity incl. NCI · Q3 FY2024: $65.7B · 10-Q 0001730168-24-000099 filed Sep 11, 2024Equity incl. NCI · Q4 FY2024: $67.7B · 10-K 0001730168-24-000139 filed Dec 20, 2024Equity incl. NCI · Q1 FY2025: $69.8B · 10-Q 0001730168-25-000021 filed Mar 12, 2025Equity incl. NCI · Q2 FY2025: $69.6B · 10-Q 0001730168-25-000064 filed Jun 11, 2025Equity incl. NCI · Q3 FY2025: $73.3B · 10-Q 0001730168-25-000098 filed Sep 10, 2025Equity incl. NCI · Q4 FY2025: $81.3B · 10-K 0001730168-25-000121 filed Dec 18, 2025Equity incl. NCI · Q1 FY2026: $79.9B · 10-Q 0001730168-26-000016 filed Mar 11, 2026Equity incl. NCI · Q2 FY2026: $87.7B · 10-Q 0001730168-26-000054 filed Jun 9, 2026Equity incl. NCI · Q3 FY2026: $99.7B · 10-Q 0001730168-26-000080 filed Sep 10, 202622.199.75.1Q1 FY2016Q3 FY2026Q3 FY2023
$BEquity incl. NCI · Q3 FY2022: $20.9B · 10-Q 0001730168-22-000094 filed Sep 8, 2022Equity incl. NCI · Q4 FY2022: $22.7B · 10-K 0001730168-22-000118 filed Dec 16, 2022Equity incl. NCI · Q1 FY2023: $23.3B · 10-Q 0001730168-23-000008 filed Mar 8, 2023Equity incl. NCI · Q2 FY2023: $22.0B · 10-Q 0001730168-23-000064 filed Jun 7, 2023Equity incl. NCI · Q3 FY2023: $22.1B · 10-Q 0001730168-23-000077 filed Sep 6, 2023Equity incl. NCI · Q4 FY2023: $24.0B · 10-K 0001730168-23-000096 filed Dec 14, 2023Equity incl. NCI · Q1 FY2024: $70.3B · 10-Q 0001730168-24-000023 filed Mar 14, 2024Equity incl. NCI · Q2 FY2024: $70.0B · 10-Q 0001730168-24-000080 filed Jun 13, 202422.170.020.970.3Q3 FY2022Q2 FY2024Q3 FY2023
Q3 FY2023
22.1$B
All values (43)
PeriodValue ($B)Status
Q3 FY202699.7reported
Q2 FY202687.7reported
Q1 FY202679.9reported
Q4 FY202581.3reported
Q3 FY202573.3reported
Q2 FY202569.6reported
Q1 FY202569.8reported
Q4 FY202467.7reported
Q3 FY202465.7reported
Q2 FY202470.0reported
Q1 FY202470.3reported
Q4 FY202324.0reported
Q3 FY202322.1reported
Q2 FY202322.0reported
Q1 FY202323.3reported
Q4 FY202222.7reported
Q3 FY202220.9reported
Q2 FY202221.0reported
Q1 FY202223.0reported
Q4 FY202125.0reported
Q3 FY202124.3reported
Q2 FY202123.9reported
Q1 FY202124.0reported
Q4 FY202023.9reported
Q3 FY202023.6reported
Q2 FY202023.9reported
Q1 FY202024.4reported
Q4 FY201924.9reported
Q3 FY201921.5reported
Q2 FY201922.2reported
Q1 FY201923.2reported
Q4 FY201826.7reported
Q3 FY201827.5reported
Q2 FY201832.1reported
Q1 FY201829.1reported
Q4 FY201723.2reported
Q3 FY201722.7reported
Q2 FY201722.3reported
Q1 FY201722.0reported
Q4 FY201621.9reported
Q3 FY201622.5reported
Q2 FY201622.8reported
Q1 FY20165.1reported

CSV with all sources · Technical ID: equity_total

More metrics for Broadcom

Value drivers

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Sources & calculation
Value
$22.1B
Period
Q3 FY2023, ended Jul 30, 2023 · as of Jul 30, 2023 (balance as of date, not a sum)
Source
10-Q, filed Sep 6, 2023 · 0001730168-23-000077
Location
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$22.1BSep 6, 202310-Q 0001730168-23-000077reported · confidence 1. · current